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Abstract. 
 
The adenomatous polyposis coli (APC) pro-
tein is implicated in the majority of hereditary and spo-
radic colon cancers. APC is known to function as a tu-
 
mor suppressor through downregulation of 
 
b
 
-catenin as
part of a high molecular weight complex known as the
 
b
 
-catenin destruction complex. The molecular composi-
tion of the intact complex and its site of action in the cell
are still not well understood. Reports on the subcellular
localization of APC in various cell systems have differed
signiﬁcantly and have been consistent with an associa-
tion with a cytosolic complex, with microtubules, with
the nucleus, or with the cortical actin cytoskeleton. To
better understand the role of APC and the destruction
complex in colorectal cancer, we have begun to charac-
terize and isolate these complexes from conﬂuent polar-
ized human colon epithelial cell monolayers and other
epithelial cell types. Subcellular fractionation and im-
munoﬂuorescence microscopy reveal that a predomi-
nant fraction of APC associates tightly with the apical
plasma membrane in a variety of epithelial cell types.
This apical membrane association is not dependent on
the mutational status of either APC or 
 
b
 
-catenin. An ad-
ditional pool of APC is cytosolic and fractionates into
two distinct high molecular weight complexes, 20S and
60S in size. Only the 20S fraction contains an apprecia-
ble portion of the cellular axin and small but detectable
amounts of glycogen synthase kinase 3
 
b
 
 and 
 
b
 
-catenin.
Therefore, it is likely to correspond to the previously
characterized 
 
b
 
-catenin destruction complex. Dishev-
elled is almost entirely cytosolic, but does not signiﬁ-
cantly cofractionate with the 20S complex. The dispro-
portionate amount of APC in the apical membrane and
the lack of other destruction complex components in the
60S fraction of APC raise questions about whether these
pools of APC take part in the degradation of 
 
b
 
-catenin,
or alternatively, whether they could be involved in other
functions of the protein that still must be determined.
Key words: adenomatous polyposis coli • destruction
complex • epithelial cells • localization • fractionation
 
Introduction
 
The tumor suppressor protein adenomatous polyposis coli
 
(APC)
 
1
 
 is implicated in the development of hereditary and
sporadic colon carcinoma (Joslyn et al., 1991; Kinzler et al.,
1991; Miyoshi et al., 1992). Mutations in the APC gene occur
early during tumor formation (Powell et al., 1992), indicat-
ing the important role of APC as the “gatekeeper” gene in
colon carcinogenesis. APC mutations generally cause chain
termination and expression of truncated proteins that lack a
COOH-terminal portion of the protein (Polakis, 1995).
An important insight into understanding the biological
function of APC has emerged through the finding that
APC binds to and regulates 
 
b
 
-catenin, a protein that func-
tions in cell adhesion as well as in signal transduction in
the Wnt signaling pathway (Rubinfeld et al., 1993; Su et
al., 1993). The best documented function of wild-type
APC is the inhibition of 
 
b
 
-catenin–mediated signaling by
stimulating the degradation of cytosolic 
 
b
 
-catenin protein
(Munemitsu et al., 1995). This function is lost in cells har-
boring APC mutations. The posttranslational stabilization
and accumulation of cytoplasmic 
 
b
 
-catenin is now consid-
ered a key mechanism in colon carcinogenesis because it
leads to the formation of 
 
b
 
-catenin/TCF transcription
complexes and the induction of target genes such as the
oncogene c-
 
myc
 
 (Korinek et al., 1997; Morin et al., 1997;
He et al., 1998). However, downregulation of 
 
b
 
-catenin
may not be the only biological role of APC. Studies in 
 
Xe-
nopus
 
 and 
 
Caenorhabditis elegans
 
 point to additional func-
tions of APC or APC-related protein potentially as an ac-
tivator of the Wnt signaling pathway (Rocheleau et al.,
1997; Vleminckx et al., 1997). Also, recent studies provide
 
Address correspondence to Barry M. Gumbiner, Cellular Biochemistry
and Biophysics Program, Memorial Sloan-Kettering Cancer Center, 1275
York Ave., Box 564, New York, NY 10021. Tel.: (212) 639-6146. Fax:
(212) 717-3047. E-mail: b-gumbiner@ski.mskcc.org
 
1
 
Abbreviations used in this paper:
 
 APC, adenomatous polyposis coli;
Dlg, 
 
Drosophila
 
 discs large; GBP/FRAT1, GSK-3–binding protein/fre-
quently rearranged in advanced T cell lymphomas 1; GSK, glycogen syn-
thase kinase. 
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evidence for a role of APC in the nuclear export of 
 
b
 
-cate-
nin (Henderson, 2000; Rosin-Arbesfeld et al., 2000).
The regulation of 
 
b
 
-catenin turnover and signaling by
APC occurs in conjunction with other proteins in a high
molecular weight complex in which 
 
b
 
-catenin is phosphor-
ylated and subsequently targeted for destruction by the
proteasome. Other key members of this destruction com-
plex are glycogen synthase kinase (GSK)-3
 
b
 
, a kinase that
presumably phosphorylates 
 
b
 
-catenin, and axin, a protein
which acts as a scaffold bringing the components of the
complex into close proximity, thereby facilitating 
 
b
 
-cate-
nin phosphorylation (Zeng et al., 1997; Polakis, 1999; Pei-
fer and Polakis, 2000). The protein dishevelled (dsh in
flies, dvl in mammals) mediates signaling from frizzled, the
Wnt receptor, and interacts with the destruction complex
to inhibit GSK-3
 
b
 
 indirectly (Kishida et al., 1999b; Li et
al., 1999; Smalley et al., 1999; Salic et al., 2000). Additional
components of the complex are the protein phosphatase
PP2A (Seeling et al., 1999) and the GSK-3
 
b
 
 inhibitor
GBP/FRAT1 (Li et al., 1999; Salic et al., 2000). Apart
from the destruction complex, APC has been found by
yeast two-hybrid assay to interact with the human homo-
logue of the 
 
Drosophila
 
 discs large tumor suppressor pro-
tein Dlg (Matsumine et al., 1996) and the microtubule
binding protein EB-1 (Su et al., 1995) and has been found
to associate with microtubules (Munemitsu et al., 1994;
Smith et al., 1994). However, the physiological relevance
of these latter interactions is not known.
Although the functional roles for APC and other compo-
nents of the destruction complex are well established, the dy-
namics of their interactions and the biochemical nature of the
complex in the cell remain poorly understood. For example,
the properties, composition, and structure of the intact iso-
lated complex have not yet been determined. Moreover, it is
not yet entirely clear where in the cell APC and the destruc-
tion complex function. A cell-free analysis of the ability of the
complex to stimulate 
 
b
 
-catenin degradation indicates that it
functions in the cytosol (Salic et al., 2000), and many bio-
chemical analyses of interactions between components are
consistent with this view (Rubinfeld et al., 1993, 1996; Hart et
al., 1998; Itoh et al., 1998). In epithelial cells of 
 
Drosophila
 
embryos, APC has been found to colocalize with cortical ac-
tin and perhaps adherens junctions (McCartney et al., 1999;
Yu and Bienz, 1999; Yu et al., 1999), whereas certain loss of
function APC mutants become more cytosolic (McCartney
et al., 1999). In several studies, APC has also been observed
to associate with microtubules (Munemitsu et al., 1994; Smith
et al., 1994; Nathke et al., 1996; Mimori-Kiyosue et al., 2000).
However, the relationship of this interaction to its known
function in 
 
b
 
-catenin degradation is not known. Other com-
ponents of the destruction complex including GSK-3
 
b
 
 and
dishevelled have often been described as soluble cytosolic
proteins (Yanagawa et al., 1995; Diehl et al., 1998). Recently
however, dishevelled has been reported to localize along ac-
tin filaments and at focal adhesions in isolated embryonic
kidney cells (Torres and Nelson, 2000) or to be associated
with cytoplasmic transport vesicles in 
 
Xenopus
 
 eggs (Miller
et al., 1999). In some experiments, dishevelled has been ob-
served to associate with the plasma membrane in response to
frizzled or soluble wingless (Yanagawa et al., 1995; Axelrod
et al., 1998; Rothbacher et al., 2000). Much less is known
about axin, but when overexpressed, it has been localized to
the plasma membrane as well as the cytoplasm (Fagotto et
al., 1999). These studies have been performed in a variety of
cell types, in some cases in the context of Wnt signaling and/
or regulation of 
 
b
 
-catenin signaling, but often without much
regard to the physiological state of the cell. Thus, to attempt
to understand the function and dynamics of the complex, it
would be very informative to examine the association and
subcellular localizations of all the endogenous components of
the complex in a well-characterized cell system in which APC
and the destruction complex are known to function.
A great deal of attention has been given to the associa-
tion of APC with microtubules. Overexpressed APC co-
distributed with or moved along microtubules in cultured
cells (Munemitsu et al., 1994; Smith et al., 1994; Mimori-
Kiyosue et al., 2000), whereas endogenous APC has some-
times been observed by immunofluorescence to localize to
the tips of protrusions of subconfluent epithelial cells
where microtubules seem to project (Nathke et al., 1996).
From these findings, it has been proposed that APC regu-
lates epithelial cell motility by virtue of its control of mi-
crotubule behavior (McCartney and Peifer, 2000). How-
ever, most of these studies were carried out on very well
spread, subconfluent epithelial cells in order to facilitate
immunofluorescence imaging and, therefore, it is not clear
how well the findings reflect the state of cells in the real
epithelia in which APC is known to function.
We chose to undertake a biochemical and cellular analysis
of APC and the destruction complex in human colon epithe-
lial tumor cells, for which the role of APC as a tumor
suppressor and regulator of 
 
b
 
-catenin signaling is well es-
tablished. Such cultured cells are homogenous and very
accessible to a variety of biochemical and microscopic ap-
proaches. We focused our efforts on fully confluent, polar-
ized cultures of these cells because we believe it is the most
physiologically relevant state for comparison to normal hu-
man colon epithelia and adenomas derived from them.
Moreover, we decided to employ a subcellular fractionation
approach in combination with immunolocalization analysis in
order to begin to isolate and characterize complexes contain-
ing the APC protein and other components of the destruc-
tion complex in polarized human colon cancer cells. Indeed,
our findings indicate that the steady state distribution of APC
differs significantly from observations on subconfluent cells,
and that it exists in multiple complexes rather than as a single
unique protein complex as had been inferred previously
(Miyahiro et al., 1995; Hart et al., 1998; Itoh et al., 1998; Po-
lakis et al., 1999; Peifer and Polakis, 2000; Salic et al., 2000).
 
Materials and Methods
 
Cell Culture
 
Colon carcinoma cell lines HCT116, DLD-1, LS411, and LoVo were ob-
tained from American Type Culture Collection and maintained in Mc-
Coy’s 5a medium/10% FBS (HCT116), RPMI 1640/10% FBS (DLD-1 and
LS411), or Ham’s F12 medium/20% FBS (LoVo), respectively. The breast
cancer cell line MCF-7 was kindly provided by Dr. N. Rosen (Memorial
Sloan-Kettering Cancer Center) and maintained in DME high glucose
supplemented with 12 nonessential amino acids and 10% FBS. MDCK II
cells were cultured in DME/10% FBS medium.
 
Cell Fractionation
 
Cell fractionation procedures were carried out at 4
 
8
 
C unless otherwise
noted. Protease inhibitors were added to solutions at the following final 
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concentrations: PMSF, 0.017 mg/ml; leupeptin, 0.002 mg/ml; aprotinin,
0.004 mg/ml; antipain, 0.01 mg/ml; benzamidine, 0.05 mg/ml; ST inhibitor,
0.01 mg/ml; iodoacetamide, 0.1 mg/ml. HCT116 and MCF-7 cells were
grown to confluency in 14-cm tissue culture dishes, washed once with PBS,
and harvested by scraping. Cells were pelleted at 200 
 
g
 
 for 5 min and re-
suspended in hypotonic lysis buffer (10 mM Tris-HCl, pH 7.8, 10 mM
KCl) and lysed by Dounce homogenization after a 20-min (HCT116) or
10-min (MCF-7) incubation on ice. Lysis was assessed by light microscopy
after staining with trypan blue. The sample was centrifuged at 5,000 rpm
for 30 min to pellet unlysed cells and nuclei. Isotonic salt concentrations
were restored (140 mM KCl) and the supernatant was further fractionated
by centrifugation at 100,000 
 
g
 
 for 1 h at 4
 
8
 
C. The resulting fractions were
labeled Pellet 100 (P100) and Supernatant 100 (S100).
 
Sucrose Equilibrium Density Gradient
Centrifugation: Flotation
 
To evaluate a potential membrane association of APC in HCT116 and
MCF-7 cells, the P100 fraction was resuspended in a 55% sucrose solution
(in buffer A: 100 mM NaCl, 20 mM Tris-HCl, pH 7.8, 5 mM EDTA) and
loaded onto 0.5 ml of a 66% sucrose solution (cushion). 5 ml of a continu-
ous 20–50% sucrose gradient was poured on top (in buffer A). The sam-
ples were spun in a Beckman Coulter SW 55Ti rotor at 45,000 rpm for 16 h
at 4
 
8
 
C. 0.55-ml fractions were collected and analyzed by Bradford protein
assay and Western blotting.
To characterize biochemical properties of APC after flotation, gradient
fractions containing plasma membrane material (sucrose concentrations
of 
 
z
 
30–37%, density 1.12–1.16 g/cm
 
3
 
) were pooled. A portion of the
membrane pool (two thirds) was treated with detergents (1% NP-40 or
1% octyl glucoside) or high salt (1 M NaCl) and spun at 100,000
 
 
 
g
 
 for 1 h.
Samples were analyzed by Western blotting.
 
Velocity Sizing of the S100 Fraction
 
To further fractionate the S100 sample according to size, velocity gradient
centrifugation was performed. 4.5 ml of a continuous 10–40% sucrose gra-
dient was layered over 0.5 ml of a 66% sucrose solution (cushion), and an
aliquot of the S100 fraction was loaded on top of the gradient. The sample
was spun at 55,000 rpm in a Beckman Coulter SW55 rotor for 4.5 h. The
marker proteins catalase (4–5S pool as monomer derived from 11.5S pool
as tetramer) and thyroglobulin (19S) were spun in parallel gradients. 625-
 
m
 
l fractions were collected and analyzed for protein content by Bradford
protein assay and Western blotting. To estimate S values 
 
.
 
19S, a software
program for simulation calculation of velocity gradients was used based
on a method developed by McEwen (1967).
 
Western Blotting
 
To detect APC, samples were separated in 3% agarose gels and trans-
ferred by capillary transfer to nitrocellulose overnight as described (Smith
et al., 1993). For the detection of E-cadherin, 
 
b
 
-catenin, dishevelled, and
axin samples were loaded on 7% SDS polyacrylamide gels (for GSK-3
 
b
 
),
on 10% SDS polyacrylamide gels, separated, and transferred to nitrocellu-
lose by semidry transfer. Western blotting was performed as described
(Vleminckx et al., 1997). The following primary antibodies were used:
APC, anti-APC NH
 
2
 
 terminus (Ab-1, mouse IgG1), anti-APC COOH ter-
minus (diluted 1:1,000) (Ab-2, mouse IgG1; Oncogene Research Prod-
ucts), or anti-APC COOH terminus (diluted 1:500) (C-20, rabbit poly-
clonal IgG; Santa Cruz Biotechnology, Inc.); 
 
b
 
-catenin, anti–
 
b
 
-catenin
NH
 
2 
 
terminus (polyclonal rabbit antiserum, diluted 1:5,000); E-cadherin,
anti–E-cadherin (diluted 1:7,500) (mouse IgG; Zymed Laboratories); and
GSK-3
 
b
 
, anti–GSK-3
 
b
 
 (diluted 1:2,500) (mouse IgG1; BD Transduction
Laboratories). Polyclonal rabbit antisera directed against murine dishev-
elled and murine axin (diluted 1:2,000) were kindly provided by R. Nusse
(Stanford University, Stanford, CA).
 
Immunofluorescence Microscopy: Cultured Cells
 
To analyze confluent epithelial cells, glass coverslips were coated with
poly–L-lysine (100
 
 m
 
g/ml) for 1 h at room temperature, and cells were al-
lowed to adhere to the coverslips for at least 72 h in appropriate culture
medium (see above). To examine cells at subconfluency, glass coverslips
were coated with collagen (50 
 
m
 
g/ml), and cells were allowed to adhere for
24–48 h. State of confluency was assessed by light microscopy before fixa-
tion. Cells were fixed (100% methanol, 5 m at 
 
2
 
20
 
8
 
C), washed three times
in PBS, blocked with BSA (1% in PBS, 30 min at room temperature), and
incubated with primary antibody (diluted in 1% BSA/PBS 1 h at room
temperature). Samples were then incubated in appropriate secondary an-
tibodies conjugated to Cy3 (Jackson ImmunoResearch Laboratories) or
FITC (Molecular Probes) (diluted 1:750 or 1:200, respectively, in 1%
BSA/PBS, 30 min at room temperature). Specimens were examined by
confocal microscopy equipped with a 25
 
3 
 
or 63
 
3 
 
objective.
Primary antibodies used for immunofluorescence microscopy were as
follows: APC, anti–human APC NH
 
2
 
 terminus (diluted 1:75) (N-15, rabbit
polyclonal IgG; Santa Cruz Biotechnology, Inc.); 
 
b
 
-catenin, anti–
 
b
 
-cate-
nin COOH terminus (diluted 1:200) (clone 14, mouse IgG; BD Transduc-
tion Laboratories); 
 
b
 
-tubulin, anti–
 
b
 
-tubulin (diluted 1:200) (clone Tub
2.1, mouse IgG; Sigma-Aldrich). As controls for APC staining, either nor-
mal rabbit IgG was substituted for the primary anti-APC antibody or an
excess of the neutralizing peptide against which the anti-APC antibody
was raised, was incubated with the anti-APC antibody before immunoflu-
orescence analysis (five times excess by weight, overnight at 4
 
8
 
C in 1%
BSA/PBS).
 
Immunofluorescence Microscopy: Tissue
 
To determine the subcellular localization of APC in mouse colon, speci-
mens were briefly washed in ice cold PBS, embedded in OCT compound
(Miles, Inc.) for 1 h on ice, and frozen in liquid nitrogen. Frozen samples
were then cut into 12-
 
m
 
m sections. Sections were air dried and fixed in
100% acetone for 10 min on ice, rehydrated in PBS, and blocked with
10% donkey serum in 2% BSA/PBS for 30 min at 37
 
8
 
C. Samples were
then incubated with primary antibody in 2% BSA/PBS for 1 h at 37
 
8
 
C
(anti-APC antibody N-15, diluted 1:50; anti–
 
b
 
-catenin antibody clone 14,
diluted 1:100). Slides were washed in 0.1% BSA/PBS for 5 min, washed in
0.05% Triton X-100/PBS for 5 min, and additionally washed in 0.1% BSA/
PBS twice for 5 min. Samples were then incubated in appropriate second-
ary antibodies conjugated to Cy3 (Jackson ImmunoResearch Laborato-
ries) or FITC (Molecular Probes) (diluted 1:750 or 1:200, respectively, in
2% BSA/PBS, 30 min at 37
 
8
 
C). After additional washing, sections were
mounted and examined by confocal microscopy equipped with a 63
 
3 
 
ob-
jective. Normal rabbit IgG and preincubation of the anti-APC antibody
with the competing peptide against which the antibody was raised were
used as controls.
Figure 1. Schematic representation of fractionation protocol
used to analyze subcellular distribution of APC and components
of the b-catenin destruction complex in HCT116 and MCF-7
cells. Cells were lysed in hypotonic lysis buffer without deter-
gents (w/o det.) and homogenized using a Dounce homogenizer.
Unbroken cells and nuclei were removed by low speed centrifu-
gation (5,000 rpm for 30 min). Postnuclear supernatants were fur-
ther fractionated by high speed centrifugation (100,000 g for 1 h)
into a pellet fraction (P100, .90S) and a supernatant fraction
(S100, ,90S). Membrane association of proteins was analyzed by
sucrose density equilibrium flotation of P100 fractions (density of
membranes z1.13 g/cm3; density of dense fractions z1.3 g/cm3).
The S100 sample was further fractionated by velocity sedimenta-
tion. Size fractions of z4–5S, z20S, and z60S were distinguished
based on distribution of total protein, APC, and axin. 
The Journal of Cell Biology, Volume 152, 2001 494
 
Results
 
APC Associates with the Apical Plasma Membrane in 
Human Epithelial Cells
 
To localize APC at the subcellular level, we initially used
the human colon carcinoma cell line HCT116, because this
cell line expresses wild-type APC. It does express a mutant
 
b
 
-catenin protein that carries a deletion of ser45 (Rubin-
feld et al., 1997). The fractionation protocol described in
Fig. 1 was used. As shown in Fig. 2 a, APC distributed ap-
proximately equally into pelletable and soluble material
after the initial 100,000-
 
g
 
 spin. This distribution pattern
was consistently observed when fully confluent monolay-
ers were used.
To determine whether the pool of APC that sedimented
at high speed (P100) was associated with membranes equi-
librium, density flotation centrifugation was performed.
With this method, APC mostly fractionated at light densi-
ties (
 
z
 
1.13 g/cm
 
3
 
) and comigrated with vesicles containing
the integral membrane protein E-cadherin, suggesting that
APC associated with membranes in HCT116 cells (Fig. 2
c). Although APC was consistently found to float with
membranes, in some experiments APC could also be de-
tected in dense fractions of the gradient (1.3 g/cm
 
3
 
) where
most of the total protein of the P100 fraction sedimented
(data not shown).
To determine the nature of the association of APC with
the membrane, this fraction was treated with mild non-
ionic detergents or high salt concentrations (Fig. 2 d).
Figure 2. Membrane association of APC in HCT116 colon carci-
noma cells. (a) Western blot showing distribution of APC after
high speed centrifugation. APC present in the postnuclear frac-
tion (PNF) distributes into both the high speed pellet fraction
(P100) and the high speed supernatant fraction (S100). Equal
proportions of P100 and S100 samples were loaded. (b) Dilution
series for measurement of APC by Western blotting. (c) APC
floats with membranes in equilibrium density gradients. Graph
and corresponding Western blot illustrating distribution of APC,
E-cadherin (marker for membranes), and total protein in each
fraction after equilibrium density flotation of P100 fractions. (d)
Solubility of membrane-bound APC after treatment with deter-
gents or high salt. Membrane-containing fractions after P100
density flotation (fractions 30–33% in panel c) were pooled,
treated with 1% NP-40, 1% octyl glucoside (OG) or 1 M NaCl,
and subjected to a high speed spin. One third of starting material
was loaded in lane M (membrane) and resulting pellet and super-
natant fractions were loaded in lanes P and S, respectively. Mem-
brane-bound APC is only partially solubilized by solubilization
of membranes with detergents, whereas high salt treatment does
not result in the release of APC into the soluble fraction. More-
over, after high salt treatment, APC continues to float with mem-
branes in density gradients (data not shown).
Figure 3. Apical localization of APC in the HCT116 colon carci-
noma cell line. Immunolocalization of endogenous APC (red)
and b-catenin (green) in HCT116 cells. (a and b) Negative con-
trol for APC and b-catenin staining, respectively. Normal mouse
(a) or normal rabbit IgG (b) was substituted for primary antibod-
ies before incubation with respective secondary antibodies. (c)
Peptide competition (1 peptide apical). Anti–b-catenin and anti-
APC antibodies were preincubated with an excess of the neutral-
izing peptide against which the anti-APC antibody was raised. A
transverse apical section is shown. (d–f) Images of successive sec-
tions of fully confluent, polarized HCT116 cells using confocal
microscopy: basal (d), intermediate (e), and apical (f) sections.
(g) Corresponding perpendicular section (z-axis). 
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High salt did not release APC from the membrane frac-
tion, suggesting that APC is tightly associated with the
membrane. Neither NP-40 nor octyl glucoside efficiently
solubilized APC. The fraction that pelleted after detergent
solubilization of membranes did not refloat during subse-
quent density equilibrium centrifugation (data not shown),
indicating that this APC subfraction is not associated with
classic lipid rafts (Simons and Ikonen, 1997), but rather is
present in a very large submembranous protein complex.
To determine where the membrane-associated fraction of
APC localizes in HCT116 cells, we used indirect immunoflu-
orescence microscopy with the polyclonal rabbit IgG anti-
body N-15 raised against an NH
 
2
 
-terminal peptide of human
APC. Immunolocalization was carried out on fully conflu-
ent, polarized epithelial cell monolayers. Confocal micro-
scopic analysis of immunostained HCT116 colon carcinoma
cells showed that APC predominantly localized to the apical
plasma membrane and to a very small degree to the apico-
lateral cell border (Fig. 3, d–g).
 
 
 
APC and 
 
b
 
-catenin, for the
most part, did not colocalize. 
 
b
 
-Catenin staining was mostly
seen laterally with very little overlap of the two proteins de-
tectable at the apicolateral cell borders (Fig. 3 g). Essentially
no APC was seen in more basal sections of the cell (Fig. 3 d).
APC staining was most pronounced in apical sections of the
cells (Fig. 3 f). The apical localization of APC is best ob-
served in the z-section of analyzed monolayers (Fig. 3 g).
For controls using normal mouse or rabbit IgG, no specific
staining was detected (Fig. 3, a and b). Furthermore, apical
staining of APC was effectively blocked by preincubation of
the antibodies with the neutralizing peptide against which
the anti-APC antibody was raised (Fig. 3 c).
Figure 4. Membrane association of APC in MCF-7 breast epithe-
lial cancer cells. (a) Western blot for APC illustrating distribution
of APC after fractionation of postnuclear fractions (PNF) into a
high speed pellet fraction (P100) and a high speed supernatant frac-
tion (S100). Equal proportions of P100 and S100 were loaded. (b)
APC in MCF-7 cells fractionates with membranes in equilibrium
density gradients. Graph illustrating relative distribution of total
protein and APC in each fraction after density flotation of P100
samples. Corresponding Western blot for APC is shown below.
Figure 5. Apical localization of APC in the MCF-7 breast tumor cell
line and the MDCK cell line. Immunolocalization of APC (red) and
b-catenin (green) in MCF-7 (a–g) and MDCK cells (h–n). Images of
successive sections of fully confluent MCF-7 and MDCK cells using
confocal microscopy. (d and k) Basal; (e and l) intermediate; and (f
and m) apical sections as well as (g and n) corresponding perpendic-
ular section (z-axis) for MCF-7 and MDCK cells. Negative controls
(substitution of normal mouse or rabbit IgG for primary antibodies)
are shown for MCF-7 cells in a and b and for MDCK cells in h and i,
respectively. (c and j) Phase–contrast image of controls. 
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Apical Membrane Localization of APC in Other 
Epithelial Cell Types and Mouse Colon
 
To determine whether the apical membrane localization
of APC is unique to the HCT116 colon carcinoma cell line
or due to the presence of a mutant 
 
b
 
-catenin found in
HCT116 cells, we analyzed the breast cancer cell line
MCF-7, which expresses wild-type 
 
b
 
-catenin and wild-type
APC. The distribution of APC during the initial 100,000-
 
g
 
spin was similar in MCF-7 cells compared with HCT116
cells. APC fractionated to about equal proportions into
pellet and supernatant (Fig. 4 a). Furthermore, as found in
HCT116 cells, APC in MCF-7 cells also sedimented at low
densities characteristic of plasma membranes during equi-
librium centrifugation, suggesting that APC similarly asso-
ciates with the plasma membrane in this cell line (Fig. 4 b).
To assess whether APC also localizes specifically to the
apical plasma membrane in MCF-7 cells, we analyzed this
cell line by confocal immunofluorescence microscopy (Fig.
5, a–g). APC localized predominantly to the apical mem-
brane and in general did not overlap with 
 
b
 
-catenin, which
mainly localized to lateral cell borders (Fig. 5, d–g; nega-
tive controls for MCF-7 cells shown in a–c). Also, to evalu-
ate APC localization in a nontransformed epithelial cell
line, we examined fully confluent, well-polarized MDCK
cells by immunofluorescence microscopy (Fig. 5, k–n; neg-
 
ative controls for MDCK cells shown in h–j). APC also lo-
calized apically in MDCK cells, whereas 
 
b
 
-catenin was
found laterally. In general, no overlap between the two
proteins was observed.
To determine where APC localizes in situ, we examined
samples of normal mouse colon by immunofluorescence
microscopy. APC was enriched at the apical membrane of
epithelial cells predominantly in upper regions of colonic
crypts towards the lumen of the digestive tract (Fig. 6, a and
b). In addition, some diffuse cytoplasmic staining was de-
tected. In contrast, b-catenin was seen mainly at the lateral
borders of colonocytes and no obvious colocalization with
APC was found. Immunoreactivity towards the APC pro-
tein in epithelial cells decreased substantially towards the
base of the crypts (Fig. 6 c). Additionally, APC was de-
tected in nonepithelial cells in the lamina propria and
throughout the submucosa and muscularis layers. APC
staining was effectively blocked with the competing peptide
against which the anti-APC antibody was raised (Fig. 6 d).
Since a lot of attention has been given to the association
of APC with microtubules, we also performed double im-
munostaining for APC and b-tubulin. In fully confluent
Figure 6. Apical membrane localization of APC in normal
mouse colon. Immunolocalization of APC (red) and b-catenin
(green) in tissue sections of normal mouse colon. (a and b) Api-
cal membrane staining of epithelial cells in the upper portion of
colonic crypts which face the lumen of the digestive tract in nor-
mal mouse colon (arrows). (c) Low APC immunoreactivity in ep-
ithelial cells towards the base of the crypts. Additional APC
staining in nonepithelial cells in the lamina propria (arrowheads)
and throughout the submucosa and muscularis layers. (d) APC
staining is effectively blocked with the specific neutralizing pep-
tide against which the antibody was raised. There is no b-catenin
staining, because normal mouse IgG was substituted for b-cate-
nin primary antibody in control sections. Note residual immu-
noreactivity of secondary anti–mouse IgG antibody with cells in
the lamina propria (green).
Figure 7. Localization of APC and microtubules in subconfluent
epithelial cells. Immunolocalization of APC (red) and b-tubulin
(green) in subconfluent HCT116 (a–c) and MDCK cells (d–e).
(a) Localization of APC at the tips of cell processes containing
microtubules is detected, albeit infrequently (,5% of all micro-
tubule-containing protrusions). (b–f) APC is present over much
of the cell surface and enriched all along the edges of the cell
body and cell protrusions. (f) Higher magnification view of e.Reinacher-Schick and Gumbiner Apical Localization of APC 497
cell monolayers, no apparent colocalization of APC and
microtubules was observed (data not shown). In subcon-
fluent HCT116 cells (Fig. 7, a–c) and subconfluent MDCK
cells (Fig. 7, d–f), APC was found over large regions of the
cell surface and perhaps in the cytoplasm. We did occa-
sionally detect APC at the tips of cell protrusions where
microtubules project, as reported previously (Nathke et
al., 1996); however, these were very rare (,5% of identi-
fied microtubule-containing protrusions) (Fig. 7 a). Much
more commonly observed was APC distributed all along
the surface of the cell protrusions (Fig. 7, b–f). Staining
patterns for HCT116 and MDCK cells were very similar.
Mutant Forms of APC also Localize to the Apical 
Membrane in Colon Carcinoma Cells
Truncations of APC are loss of function mutations that are
responsible for loss of tumor suppressor activity. There-
fore, we asked whether truncation mutations in APC af-
fect its apical membrane localization. The distributions of
APC in several colon carcinoma cell lines with known
truncations of the APC protein were examined by confo-
cal immunofluorescence microscopy. The linear represen-
tation of the full-length human APC protein is shown in
Fig. 8 a. The DLD-1 cell line (Fig. 8, b–e) harbors a trunca-
tion mutation within the central region of the APC pro-
tein, a region which is known to be crucial for the tu-
mor suppressor activity of APC through downregulating
b-catenin (Munemitsu et al., 1995). The cell line LoVo
(Fig. 8, f–i) carries a mutation at codon 1114 of APC, re-
taining the NH2 terminus of APC including one of the
three 15–amino acid repeats. The cell line LS411 (Fig. 8, j–m)
carries a mutation at codon 789 which causes chain termi-
nation shortly after the seven armadillo repeats (Homfray
et al., 1998). A polyclonal antibody directed against the
NH2 terminus of the APC protein was used to detect APC.
In all cell lines, the mutant APC protein predominantly lo-
calized to the apical plasma membrane as observed in se-
rial transverse sections through confluent monolayers.
Again, most APC protein did not colocalize with most of
the lateral membrane-associated b-catenin in DLD-1,
LoVo, and LS411 cells. APC staining was effectively abol-
ished by competition with the specific neutralizing peptide
Figure 8. Localization of mutant forms of APC to the apical
membrane in colon cancer cell lines. (a) Linear representation of
the full-length human APC protein. Several known motifs are
shown on top, including the oligomerization domain (oligom.),
armadillo repeats (arm. repeats), the 15– and 20–amino acid re-
peats (both known to bind b-catenin), basic domain, and Dlg
binding site. Regions for axin binding are shown below. Immu-
nolocalization of APC (red) and b-catenin (green) in DLD-1 (b–
e), LoVo (f–i), and LS411 (j–m) cells. Linear representation of
truncated mutant forms of the APC protein expressed by the re-
spective cell line is also shown. Images of successive sections of
fully confluent DLD-1, LoVo, and LS411 cells using confocal mi-
croscopy. (b, f, and j) Basal; (c, g, and k) intermediate; and (d, h,
and l) apical sections are shown. (e, i, and m) Peptide competi-
tion (1 peptide apical). Apical section through DLD-1 (e), LoVo
(i), and LS411 cells (m) after preincubation of primary anti–
b-catenin and anti-APC antibodies with the neutralizing peptide
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against which the anti-APC antibody was raised (Fig. 8, e,
i, and m). These data suggest that an NH2-terminal frag-
ment of the APC protein containing the oligomerization
domain and the arm repeat region is sufficient to localize
APC to the apical membrane.
APC Fractionates into Multiple Subcellular Pools in 
Human Epithelial Cells but Does Not Completely 
Cofractionate with Known Components of the
b-Catenin Destruction Complex
Although most of the APC localized to the apical mem-
brane in epithelial cells by immunofluorescence, we did
identify a soluble pool of APC biochemically upon initial
high speed centrifugation (Fig. 2 a). To characterize the
soluble fraction of APC further, we determined the size of
APC-containing protein complexes by velocity gradient
centrifugation. With this method, APC sedimented in two
size-fractions corresponding to sedimentation coefficients
of z20S and 60S (Figs. 9 c and 10 c). In particular, the 60S
pool of APC fractionated away from most of the total pro-
tein in the S100 fraction, most of which sedimented at a
smaller size of z4–5S and some at z20S (data not shown).
This distribution pattern of APC into two distinct pools
was repeatedly observed in multiple experiments.
A convergence of biochemical and genetic studies have
shown that APC can form complexes with several proteins
in the Wnt signaling pathway, including b-catenin, axin, di-
shevelled, and GSK-3b. APC and its binding partners are
thought to form a high molecular weight complex (called
the destruction complex) that affects b-catenin signaling by
catalyzing b-catenin phosphorylation, which is a prerequi-
site for proteasomal degradation of b-catenin. To get a bet-
ter understanding of the localization of the destruction
complex in epithelial cells, we determined the subcellular
distribution of key components of the complex in conflu-
ent polarized epithelial cells. After high speed centrifuga-
tion of the postnuclear fraction from HCT116 cells, axin,
Figure 9. Distinct fractionation pattern of components of the
b-catenin destruction complex in HCT116 cells. Cells were frac-
tionated according to the scheme in Fig. 1 and analyzed by West-
ern blotting for APC, b-catenin (b-Cat), axin, dishevelled (Dvl),
and GSK-3b (GSK). (a) Distribution of proteins into pellet
(P100) and supernatant (S100) after high speed centrifugation.
Equal proportions of P100 and S100 were loaded. Note that axin,
dishevelled, and GSK are mostly cytosolic. (b) Distribution of
proteins of the destruction complex and b-catenin after density
equilibrium flotation of P100 fractions. Note that only a small
fraction of total axin, dishevelled, and GSK-3b is analyzed by
P100 flotation since these components are mostly cytosolic. (c)
Distribution of components of the destruction complex and b-cat-
enin after velocity sizing of S100 fractions. APC distributes into
two high molecular weight pools of z20S and 60S.
Figure 10. Distinct fractionation pattern of components of the
b-catenin destruction complex in MCF-7 breast cancer cells.
Cells were fractionated according to the scheme in Fig. 1 and
fractions were analyzed by Western blotting for APC, b-catenin,
axin, dishevelled, and GSK-3b. (a) Distribution of proteins into
high speed pellet (P100) and high speed supernatant (S100) frac-
tions. Equal proportions of the fractions were loaded. Note that
axin, dishevelled, and GSK-3b are predominantly cytosolic. (b)
Distribution of components of the destruction complex and
b-catenin after density flotation of P100 fractions. Note that only
a small fraction of total axin, dishevelled, and GSK-3b is ana-
lyzed by P100 flotation since these components are mostly cyto-
solic. (c) Distribution of components of the destruction complex
after velocity centrifugation of S100 fractions. Similar to HCT116
cells, APC distributes into two high molecular weight peaks of
z20S and z60S in MCF-7 cells.Reinacher-Schick and Gumbiner Apical Localization of APC 499
dishevelled, and GSK-3b remained largely cytosolic,
whereas APC distributed to about equal proportions into
pellet and supernatant (Fig. 9 a). b-Catenin pelleted al-
most completely during this fractionation step, presumably
because most of the b-catenin in HCT116 cells is bound to
the membrane protein E-cadherin. To determine whether
the small fractions of axin, dishevelled, and GSK-3b that
sedimented at 100,000 g codistributed with APC and mem-
branes, equilibrium density flotation gradients were run
(Fig. 9 b). As before, most of the APC present in the P100
floated with membranes (assessed by its codistribution
with  b-catenin), whereas small amounts of axin and GSK-
3b were detected in both the membrane and the dense
fractions of the gradient. On the contrary, none of the
small fraction of dishevelled protein present in the P100
floated with membranes, but rather sedimented with the
bulk of the protein in gradient fractions with high densities.
With the antibodies used, two forms of axin and dishev-
elled were consistently detected by Western blotting. The
higher molecular weight form of dishevelled distributed
mostly in the S100 fraction (Fig. 9 a). For axin, small amounts
of a higher molecular weight form were seen in the P100 frac-
tion and were enriched in membrane fractions after flotation
of the P100 (Fig. 9 b). The significance of these distinct immu-
noreactive forms of axin and dishevelled is unclear.
To determine whether the large soluble pool of the com-
ponents of the destruction complex cofractionates with
APC, the S100 fraction of HCT116 cells was analyzed by ve-
locity gradient centrifugation (Fig. 9 c). Most of the soluble
b-catenin, dishevelled, and GSK-3b sedimented at a size
range of z4–5S. Only minor portions of GSK-3b and b-cat-
enin overlapped with APC in the 20S fraction. Axin, on the
other hand, was almost exclusively present in the 20S frac-
tion of the gradient, thereby significantly cofractionating
with the 20S pool of APC. None of axin, dishevelled, GSK-
3b, or b-catenin codistributed with the 60S pool of APC in
HCT116 cells. A summary of the overall approximate distri-
butions of APC and components of the b-catenin destruc-
tion complex in HCT116 cells is depicted in Table I.
To assess whether the distributions of these proteins
were unique to HCT116 cells or dependent on the NH2-
terminal mutation of b-catenin expressed by this cell line,
we also analyzed their fractionation patterns in the breast
cancer cell line MCF-7 (Fig. 10). APC as well as b-catenin,
axin, dishevelled, and GSK-3b distributed into subcellular
pools in MCF-7 cells very similar to HCT116 cells. APC
fractionated equally into P100 and S100 pools, whereas
axin, dishevelled, and GSK-3b were largely soluble and
b-catenin mostly pelleted (Fig. 10 a). In density flotation
gradients, most complex components from MCF-7 cells
behaved comparable to those from HCT116 cells (Fig. 10
b). APC and b-catenin mostly floated with membranes,
whereas the small amounts of particulate dishevelled were
mainly detected in dense fractions. In contrast to the
HCT116 cells where the small P100 pools of axin and
GSK-3b distributed in both membrane and dense frac-
tions, the small pool of particulate axin fractionated exclu-
sively in membrane fractions, and most of the pelletable
GSK-3b sedimented in the dense fractions. Nonetheless,
because the fraction of axin and GSK-3b present in the
P100 before flotation is minor compared with the soluble
pool of these proteins (see Fig. 10 a), their overall distribu-
tions are very similar in HCT116 and MCF-7 cells.
The fractionation pattern of the major soluble pool of
the destruction complex in MCF-7 cells was also analyzed
by velocity sizing (Fig. 10 c). Largely identical to HCT116
cells, APC fractionated into two peaks, a 20S and a 60S
fraction, whereas b-catenin, dishevelled, and GSK-3b again
distributed into the 4–5S fraction. Axin was again mainly
found in the 20S pool, thus overlapping with the 20S frac-
tion of APC. Again, none of the components of the de-
struction complex fractionated with the 60S pool of APC.
Discussion
We have found that the tumor suppressor protein APC is
associated with the apical plasma membrane in a variety of
polarized epithelial cells. In contrast, only small amounts
of axin and GSK-3b, but no dishevelled, are associated
with membranes. In addition to the apical membrane pool,
APC is present in a cytosolic pool which fractionates into
two distinct high molecular weight complexes of z20S and
60S. Most of the cellular axin codistributes with APC in the
20S fraction, whereas most of the dishevelled and GSK-3b
are found uncomplexed (4–5S). Interestingly, none of the
components of the destruction complex copurify with APC
in the 60S fraction (for a summary see Table I).
The association of APC with the apical plasma mem-
brane of polarized epithelial cells is not unique to colorec-
tal cell lines nor is it due to the activating mutation in
b-catenin present in HCT116 cells. APC is also apical in
MCF-7 breast cancer cells and MDCK cells, both of which
express wild-type b-catenin and APC. Moreover, APC is
enriched at the apical membrane of epithelial cells in nor-
mal colon tissue in the upper portion of crypts towards the
lumen of the digestive tract. Others have also reported
some concentration of APC in apical regions of mouse and
human intestinal cells (Miyashiro et al., 1995; Senda et al.,
1996; Midgley et al., 1997). Furthermore, the reported cor-
tical localization of APC in numerous epithelial cell types
Table I. Summary of Distribution of Components of the b-Catenin Destruction Complex in Subcellular Fractions of HCT116 Colon 
Carcinoma Cells
Protein Membrane association Soluble fraction Soluble fraction size
APC z50% membrane; apical z50% soluble 20S and 60S
b-Catenin .90% membrane; lateral ,10% soluble 4–5S*
Axin z5–10% membrane   90–95% soluble 20S
Dishevelled ,5% membrane .95% soluble 4–5S
GSK-3b z5–10% membrane 90–95% soluble 4–5S*
Data from Fig. 9 resulting from fractionation according to Fig. 1 are summarized. Fraction and percent values are approximate; ranges reflect experiment to experiment variability.
*Small amounts of protein from 4–5S peak also present in 20S fraction.The Journal of Cell Biology, Volume 152, 2001 500
in the Drosophila embryo often appears to be concen-
trated at the apical cell surface (McCartney et al., 1999; Yu
and Bienz, 1999; Yu et al., 1999). Thus, we propose that
the association of APC with the apical membrane is wide-
spread in a variety of epithelia.
Inactivating truncation mutations in APC do not alter
its localization to the apical membrane, indicating that loss
of its tumor suppressor function is not attributable to al-
terations in its localization. Rather, the known tumor sup-
pressor function of APC, that is, the downregulation of
b-catenin, resides in the central region of the protein (Mu-
nemitsu et al., 1995; Hart et al., 1998), a region that is not
present in the truncated APC proteins that still localize
apically. These findings also demonstrate that apical local-
ization does not depend on binding to axin, b-catenin, or
any other component of the destruction complex that in-
teracts with the central third of the protein. Although our
findings do not precisely determine the amino acid se-
quence of APC required for apical localization, it is worth
noting that the NH2-terminal quarter fragment sufficient
for apical localization in LS411 cells still retains the arma-
dillo repeat domain, a region with high homology to b-cat-
enin and related proteins. The membrane association of a
mutant form of Drosophila APC2 that carries a deletion of
a single amino acid within the arm repeat region (Ser 241)
is largely abolished (McCartney et al., 1999), suggesting
that an intact arm repeat region is necessary for mem-
brane localization. It will be interesting to determine
whether the arm repeat domain interacts, either directly or
indirectly, with apical membrane proteins.
It is not yet known whether the apical membrane-associ-
ated pool of wild-type APC is functional in the regulation
of b-catenin degradation. Cell-free assays and studies on
APC expression in cultured cells have implied that it func-
tions in the cytosol (Munemitsu et al., 1995; Salic et al.,
2000). In contrast, genetic studies in Drosophila have
linked the membrane association of APC to its function as
an inhibitor of the wingless/b-catenin signaling pathway,
because loss of function mutant forms of APC accumulate
in the cytoplasmic pool (McCartney et al., 1999). How-
ever, we find that most of the other components of the de-
struction complex, axin, dishevelled, and GSK-3b, are pre-
dominately soluble after high speed centrifugation. There
are minor portions of cellular axin and GSK-3b in the
membrane fraction that could be associated with APC, but
the distribution of APC in the membrane fraction is
clearly disproportionate relative to other members of the
complex. Also very little, if any, b-catenin colocalizes with
APC at the apical membrane. It is possible that apical
membrane-associated APC interacts with b-catenin and
other components of the destruction complex transiently
(Salic et al., 2000). Alternatively, apical APC could be a
stored and/or inactive pool, with its release into the cytosol
regulated physiologically. Finally, apical APC may have
additional biological functions not yet elucidated.
A large soluble pool of APC was also detected by cell
fractionation. This cytosolic pool was not apparent by im-
munofluorescence microscopy, presumably because it is
extracted during fixation and/or the signal is diluted over
the volume of the cell. We also did not detect nuclear APC
by immunofluorescence in fully confluent epithelial cells,
although as reported by others (Henderson, 2000; Rosin-
Arbesfeld et al., 2000) mutant APC was detected in the
nucleus at subconfluency in some cell lines (data not
shown). It is unlikely that the soluble pool of APC arises
artifactually by dissociation from the membrane during
fractionation, because APC is tightly associated with the
membrane under the conditions used. The 20S pool of sol-
uble APC cofractionates with some of the other compo-
nents of the destruction complex, including most of the
axin and small amounts of the GSK-3b and b-catenin. This
20S pool is similar in nature to the pool of APC that has
been studied in previous studies on the b-catenin destruc-
tion complex by coimmunoprecipitation and gel filtration
analyses of detergent lysates (Rubinfeld et al., 1993, 1996;
Hart et al., 1998; Itoh et al., 1998; Kishida et al., 1999a).
However, only minor portions of the total GSK-3b and
b-catenin, and very little, if any, dishevelled are present in
this fraction. These proteins may interact with the destruc-
tion complex dynamically (Salic et al., 2000) or may serve
other functions in some cells (i.e., GSK-3b in the insulin
and other signaling pathways, dishevelled in the planar cell
polarity pathway, and b-catenin in cell–cell adhesion)
(Axelrod et al., 1998; Boutros et al., 1998; Srivastava and
Pandey, 1998; Wallingford et al., 2000). We propose,
therefore, that the APC-associated destruction complex
described in previous reports corresponds to the 20S pool
of APC that we detect in this study.
If the destruction complex fractionates at 20S, one may
ask what is the function of the APC in the 60S fraction?
None of the other components of the destruction complex
were detected in this fraction. The lack of axin in the 60S
fraction indicates that it is not simply a higher order as-
sembly of the 20S complex. This raises the possibility that
the different APC pools identified in this study (apical,
20S, and 60S) are independent of each other and that the
60S pool of APC may have novel functions in the cell. In-
deed, the known function of APC in the destruction com-
plex is mediated by the central region of this large and
complicated protein, yet the NH2- and COOH-terminal
regions contain interesting domains with less established
cellular functions. Furthermore, there is evidence that
APC and an APC related protein (APR-1) may have addi-
tional, possibly positive acting functions in the Wnt signal-
ing pathway in C. elegans and Xenopus embryos (Roche-
leau et al., 1997; Vleminckx et al., 1997; Nelson and
Gumbiner, 1999; Guger and Gumbiner, 2000; Hoier et al.,
2000). Also, the relationship of the 60S and/or membrane
pool to the recently described nuclear export function of
APC is not yet known (Henderson, 2000; Rosin-Arbesfeld
et al., 2000).
APC has been reported to be associated with microtu-
bules (Munemitsu et al., 1994; Smith et al., 1994; Mimori-
Kiyosue et al., 2000), and therefore has been proposed to
regulate microtubule function and cell migration (Nathke
et al., 1996; McCartney and Peifer, 2000). We found APC
to be largely localized at the apical membrane, with no ap-
parent colocalization with microtubules. Our study was
carried out on fully confluent polarized epithelial cells,
conditions that correspond to the situation in intact epi-
thelial tissue in vivo. Similar to earlier studies (Nathke et
al., 1996), we could detect endogenous APC at the tips of
microtubule-containing cell extensions in cells at subcon-
fluency. However, these were infrequent, and in mostReinacher-Schick and Gumbiner Apical Localization of APC 501
cells, APC staining was observed all over the cell surface
and all along the extensions. Considering the recent find-
ing that APC moves along microtubules in subconfluent
cultured cells (Mimori-Kiyosue et al., 2000), one explana-
tion for all of the reported findings is that APC is trans-
ported to the apical membrane via microtubules as cells
form polarized epithelia.
The polarization of APC to the apical membrane do-
main may have implications for a function in epithelial de-
velopment. For example, localizing the degradation ma-
chinery to the apical membrane could serve to keep the
destruction activity segregated away from the pool of b-cat-
enin in cadherin adhesion complexes at the lateral mem-
brane. Conversely, active destruction of b-catenin at the
apical surface could help keep the apical luminal surface
nonadhesive and help maintain epithelial polarity. An-
other speculation is that apically localized APC could play
a role in asymmetric cell division by localizing signaling de-
terminants, similar to other apical proteins that control the
localization of cell fate determinants during asymmetric
cell division in Drosophila (e.g., crumbs, bazooka, inscute-
able, and pins) (Knust, 1994; Lu et al., 1998; Schweisguth,
2000). Indeed, the Wnt signaling pathway regulates asym-
metric cell division and anterior–posterior cell fate specifi-
cation in early C. elegans embryos (Lu et al., 1998). Re-
gardless of the specific model, the apical localization of
APC suggests that APC plays some role in the compart-
mentalization of signaling functions or in cell polarity.
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